Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy
- 21 April 2009
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 39 (7) , 1088-1098
Abstract
Summary: Background Specifically designed recombinant allergens with reduced IgE reactivity are promising candidates for a more defined, effective, and safer specific immunotherapy (SIT).Objective We sought to obtain hypoallergenic hybrid molecules which could potentially be applied to house dust mite (HDM) allergy treatment.Methods Two hybrid molecules (QM1 and QM2) derived from the two major Dermatophagoides pteronyssinus allergens, Der p 1 and Der p 2, were engineered by PCR, produced in Escherichia coli, and purified. The overall IgE‐binding capacity of the hybrids was compared with their single components by Western blot, specific IgE, skin prick test (SPT), and IgE‐inhibition assays. T cell proliferation assay were performed to confirm their retention of T cell reactivity. Immune responses to the hybrid molecules were studied in BALB/c mice.Results The IgE reactivity of both hybrid proteins was strongly reduced as evaluated by in vitro methods. Furthermore, in vivo SPTs performed on 106 HDM‐allergic patients showed that the hybrid proteins had a significantly lower potency to induce cutaneous reactions than the individual components. Hybrid molecules induced higher T cell proliferation responses than those produced by an equimolecular mixture of Der p 1 and Der p 2. Immunization of mice with the hybrid proteins induced Der p 1‐ and Der p 2‐specific IgG, which inhibited the binding of allergic patients' IgE to these natural allergens.Conclusion QM1 and QM2 hybrids exhibited less IgE‐binding activity but preserved immunogenicity and fulfilled the basic requirements for hypoallergenic molecules suitable for a future SIT of HDM allergy.Keywords
This publication has 52 references indexed in Scilit:
- Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivativesClinical & Experimental Allergy, 2008
- A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6Biological Chemistry, 2008
- Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineeringMolecular Immunology, 2008
- Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergenJournal of Allergy and Clinical Immunology, 2006
- Allergen-specific immunotherapy with recombinant grass pollen allergensJournal of Allergy and Clinical Immunology, 2005
- Component‐resolved diagnosis of house‐dust mite allergy with purified natural and recombinant mite allergensClinical & Experimental Allergy, 2004
- The Crystal Structure of a Major Dust Mite Allergen Der p 2, and its Biological ImplicationsJournal of Molecular Biology, 2002
- Comparison of the levels of the major allergens Der p I and Der p II in standardized extracts of the house dust mite, Dermatophagoides pteronyssinusClinical & Experimental Allergy, 1994
- Analysis of human T cell responses to the group II allergen of Dermatophagoides species: Localization of major antigenic sitesJournal of Allergy and Clinical Immunology, 1993
- Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1Journal of Allergy and Clinical Immunology, 1988